Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 21 06 2022
accepted: 03 08 2022
revised: 20 07 2022
pubmed: 11 8 2022
medline: 28 9 2022
entrez: 10 8 2022
Statut: ppublish

Résumé

Pediatric multi-system inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) is a serious complication of a previous SARS-CoV-2 infection. The disease causes multiple organ failure, but in some patients, a more severe course of the disease is observed. The treatment is multidirectional and depends on the severity and course of the disease, as some patients do not respond to the recommended treatment. The aim of this study was to identify laboratory risk factors affecting the more severe course of the disease and resistance to standard therapy. It is a single-center retrospective study considering 51 patients with PIMS-TS. Clinical features, laboratory results, and additional imaging tests data were taken into account. Fifty-one patients with PIMS-TS were hospitalized within a 16-month observation period. In the studied group, 26/51 children (51%) were girls. The mean age of patients was 7 years. Sex of the patient was not a risk factor for changes in cardiovascular system or severe course of the disease. Sixteen patients (31.3%) required transfer to the intensive care unit. Children with initially higher concentrations of NT-proBNP, troponin, creatinine, triglycerides, C-reactive protein, procalcitonin, ferritin, D-dimers and lower hematocrit, platelet count, lymphocytes, and ejection fraction should be strictly observed as they have a higher risk of severe course of the disease. Laboratory parameters especially markers of myocardial damage, markers of inflammation, blood count, as wells as biochemical parameters are significant risk indicators of severe course of PIMS -TS and their concentration can be defined as predictor of disease severity. • Pediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) is a serious complication of a previous SARS-CoV-2 infection in the group of pediatric patients • Course of the disease may be severe, which may cause long-term complications and the need for longitudinal patient care. • Children with higher concentrations of NT-proBNP, troponin, creatinine, TG, CRP, PCT, ferritin, D-dimers and lower hematocrit, PLT, lymphocytes, and EF have a higher risk of a severe course of the disease. • Patients with high concentration of NT-proBNP, troponin, CRP, lactates, ferritin, D-dimers, creatinine and a lower concentration of PLT, albumin, leukocytes; lymphopenia, hyponatremia are at risk for intravenous immunoglobulin resistance.

Identifiants

pubmed: 35948653
doi: 10.1007/s00431-022-04584-8
pii: 10.1007/s00431-022-04584-8
pmc: PMC9364844
doi:

Substances chimiques

Immunoglobulins, Intravenous 0
Lactates 0
Procalcitonin 0
Triglycerides 0
Troponin 0
C-Reactive Protein 9007-41-4
Ferritins 9007-73-2
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3733-3738

Subventions

Organisme : Uniwersytet Medyczny w Lodzi
ID : 503/8-000-01/503-81-001-19-00

Informations de copyright

© 2022. The Author(s).

Références

Lancet Child Adolesc Health. 2020 Sep;4(9):669-677
pubmed: 32653054
Int J Mol Sci. 2021 Apr 26;22(9):
pubmed: 33925779
SN Compr Clin Med. 2021;3(1):48-59
pubmed: 33437929
Front Pediatr. 2021 May 28;9:681626
pubmed: 34123977
Physiol Res. 2021 Apr 30;70(2):153-159
pubmed: 33992044
Kardiol Pol. 2021;79(12):1365-1367
pubmed: 34704607
Circulation. 2021 Jan 5;143(1):78-88
pubmed: 33166178
Lancet Child Adolesc Health. 2021 May;5(5):323-331
pubmed: 33711293

Auteurs

Aleksandra Stasiak (A)

Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Sporna 36/50 street, 91-738, Lodz, Poland. aleksandra.stasiak1@stud.umed.lodz.pl.

Ewelina Perdas (E)

Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.

Elżbieta Smolewska (E)

Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Sporna 36/50 street, 91-738, Lodz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH